|
Women
n = 32% (frequency)
|
Men
n = 7% (frequency)
|
p valuea
|
---|
MALT lymphoma
|
56% (18/32)
|
57% (4/7)
|
1.00
|
DLBCL
|
16% (5/32)
|
0% (0/7)
|
0.56
|
Follicular lymphoma
|
6% (2/32)
|
14% (1/7)
|
–
|
Myeloma
|
3% (1/32)
|
0% (0/7)
|
–
|
CLL
|
3% (1/32)
|
0% (0/7)
|
–
|
Lymphoplasmacytic lymphoma
|
0% (0/32)
|
14% (1/7)
|
–
|
Other NHL
|
13% (4/32)
|
14% (1/7)
|
–
|
Hodgkin lymphoma
|
3% (1/32)
|
0% (0/7)
|
–
|
- According to the WHO 2016 classification
-
aCalculated when n ≥ 5 for either group
-
MALT mucosa-associated lymphoid tissue, DLBCL diffuse large B cell lymphoma, CLL Chronic lymphatic leukemia, NHL non-Hodgkin lymphoma